Your session is about to expire
← Back to Search
Procedure
ExAblate Transcranial System for Brain Tumor
N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of exablate procedure
Awards & highlights
Summary
This trial will test whether transcranial MRI-guided focused ultrasound surgery is safe and effective in treating brain tumors.
Eligible Conditions
- Brain Tumor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of exablate procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of exablate procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluate Safety of ExAblate Transcranial Device
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExAblate Transcranial DeviceExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ExAblate Transcranial System
2011
N/A
~30
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
90 Previous Clinical Trials
3,787 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger